Ifp Advisors, Inc Tg Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 178,547 shares of TGTX stock, worth $6.27 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

178,547

Previous 123,564 44.5%

Holding current value

$6.27 Million

Previous $2.89 Million 85.95%

% of portfolio

0.18%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$21.31 - $35.09 $1.17 Million - $1.93 Million	54,983 Added 44.5%	178,547 $5.37 Million
Q3 2024 Feb 04, 2025	BUY	$17.21 - $25.28 $2.13 Million - $3.12 Million	123,564 New	123,564 $2.89 Million
Q1 2024 Jul 30, 2024	BUY	$13.02 - $21.3 $833 - $1,363	64 New	64 $0
Q2 2023 Aug 04, 2023	SELL	$15.48 - $35.0 $15,480 - $35,000	-1,000 Reduced 90.91%	100 $2,000
Q1 2023 Apr 18, 2023	SELL	$10.23 - $19.34 $265 - $502	-26 Reduced 2.31%	1,100 $16,000
Q4 2022 Feb 07, 2023	BUY	$5.01 - $11.83 $5,085 - $12,007	1,015 Added 914.41%	1,126 $16,000
Q3 2022 Nov 08, 2022	BUY	$4.57 - $8.4 $41 - $75	9 Added 8.82%	111 $3,000
Q2 2022 Sep 06, 2022	BUY	$3.74 - $10.66 $381 - $1,087	102 New	102 $2,000
Q2 2022 Aug 12, 2022	SELL	$3.74 - $10.66 $381 - $1,087	-102 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$7.81 - $20.45 $15 - $40	2 Added 2.0%	102 $0
Q3 2021 Oct 06, 2021	SELL	$21.78 - $40.45 $11,238 - $20,872	-516 Reduced 83.77%	100 $3,000
Q2 2021 Jul 13, 2021	SELL	$32.5 - $48.96 $3,835 - $5,777	-118 Reduced 16.08%	616 $25,000
Q1 2021 Apr 30, 2021	BUY	$41.61 - $54.3 $15,062 - $19,656	362 Added 97.31%	734 $36,000
Q4 2020 Jan 25, 2021	BUY	$25.27 - $54.9 $8,111 - $17,622	321 Added 629.41%	372 $20,000
Q3 2020 Oct 29, 2020	BUY	$18.49 - $27.24 $942 - $1,389	51 New	51 $2,000
Q1 2019 May 15, 2019	SELL	$4.02 - $8.04 $3,014 - $6,029	-750 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$3.44 - $5.76 $4,988 - $8,352	-1,450 Reduced 65.91%	750 $3,000
Q3 2018 Oct 25, 2018	BUY	$5.15 - $14.0 $1,030 - $2,800	200 Added 10.0%	2,200 $0
Q2 2018 Aug 07, 2018	BUY	$12.5 - $15.0 $6,250 - $7,500	500 Added 33.33%	2,000 $0
Q1 2018 Jun 03, 2019	SELL	$8.7 - $16.8 $1,739 - $3,360	-200 Reduced 11.76%	1,500 $12,000
Q1 2018 May 09, 2018	BUY	$8.7 - $16.8 $1,739 - $3,360	200 Added 13.33%	1,700 $0
Q4 2017 Jan 24, 2018	SELL	$7.35 - $12.3 $3,307 - $5,535	-450 Reduced 23.08%	1,500 $0
Q3 2017 Oct 30, 2017	SELL	$10.0 - $12.7 $19,000 - $24,130	-1,900 Reduced 49.35%	1,950 $23,000
Q2 2017 Jun 03, 2019	BUY	N/A	2,850 Added 285.0%	3,850 $39,000
Q4 2016 Jun 03, 2019	BUY	N/A	750 Added 300.0%	1,000 $5,000
Q2 2016 Jun 03, 2019	BUY	N/A	250	250 $2,000

Others Institutions Holding TGTX

# of Institutions

372

Shares Held

85.5M

Call Options Held

3.78M

Put Options Held

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.1B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account